← Back
$INO All transactions

INOVIO PHARMACEUTICALS, INC.

F

$ Value

$24K

Shares

13,657

Price

$2

Filed

Feb 27

Insider

Name

Shea Jacqueline Elizabeth

Title

Chief Executive Officer

CIK

0001771498

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-26

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

85,004

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 was as follows: 18,632 shares vested on February 26, 2025; 18,632 shares vested on February 26, 2026; and 18,631 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. | The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. | Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 was as follows: 28,401 shares vested on February 26, 2026; 28,400 shares will vest on February 26, 2027; 28,400 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. | The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein.

Filing Info

Accession No.

0001771498-26-000002

Form Type

4

Issuer CIK

0001055726

Shea Jacqueline Elizabeth's History

Date Ticker Type Value
2026-03-04 INO A $0
2026-03-04 INO A $0
2026-02-26 INO M
2026-02-26 INO F $14K
2026-02-26 INO M
2026-02-26 INO F $24K
2026-02-26 INO M $0
2026-02-26 INO M $0
2025-05-20 INO A $0
2025-05-20 INO A $0

Other Insiders at INO (90d)

Insider Bought Sold Last
KIES PETER
CFO
2026-03-04
Weiner David B. 2026-02-26
Humeau Laurent
Chief Scientific Officer
2026-03-04
Shea Jacqueline Elizabeth
Chief Executive Officer
2026-03-04
Sumner Michael John
Chief Medical Officer
2026-03-31